Clinical Outcomes of Small Cell Glioblastoma or Glioblastoma With Oligodendroglioma Component Treated With Radiation Therapy and Temozolomide

被引：0
|
作者：
Huang, J. [1 ]
Badiyan, S. N. [1 ]
Cai, C. [1 ]
Robinson, C. G. [1 ]
Dahiya, S. [1 ]
Tran, D. D. [1 ]
Kim, A. H. [1 ]
Dunn, G. P. [1 ]
Campian, J. L. [1 ]
Chicoine, M. R. [1 ]
Simpson, J. R. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.990
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2191
引用
收藏
页码：S293 / S294
页数：2
相关论文
共 50 条
  • [21] AMPAR antagonist enhance the effect of temozolomide and radiation on glioblastoma cell
    Yoshida, Y.
    Ishiuchi, S.
    Suzuki, Y.
    Nakano, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S612 - S613
  • [22] Pediatric glioblastoma with oligodendroglioma component: Aggressive clinical phenotype with distinct molecular characteristics
    Mizoguchi, Masahiro
    Hata, Nobuhiro
    Suzuki, Satoshi O.
    Fujioka, Yutaka
    Murata, Hideki
    Amano, Toshiyuki
    Nakamizo, Akira
    Yoshimoto, Koji
    Iwaki, Toru
    Sasaki, Tomio
    NEUROPATHOLOGY, 2013, 33 (06) : 652 - 657
  • [23] Integrated Genomic and Transcriptomic Analysis of Glioblastoma with Oligodendroglioma Component
    Hinrichs, B. H.
    Newman, S.
    Rossi, M. R.
    Brat, D. J.
    MODERN PATHOLOGY, 2014, 27 : 437A - 437A
  • [24] Elderly Patients With Glioblastoma Multiforme Treated With Concurrent Temozolomide and Standard Radiation Therapy or Hypofractionated Radiation Therapy With Subset MGMT Analysis
    Chang-Halpenny, C. N.
    Yeh, J. X.
    Kaptein, J. S.
    Lien, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S247 - S248
  • [25] Integrated Genomic and Transcriptomic Analysis of Glioblastoma with Oligodendroglioma Component
    Hinrichs, B. H.
    Newman, S.
    Rossi, M. R.
    Brat, D. J.
    LABORATORY INVESTIGATION, 2014, 94 : 437A - 437A
  • [26] Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide
    Tseng, Han-Min
    Kuo, Lu-Ting
    Lien, Huang-Chun
    Liu, Kao-Lang
    Liu, Mu-Tai
    Huang, Chao-Yuan
    ANTI-CANCER DRUGS, 2010, 21 (10) : 963 - 967
  • [27] Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma
    Shafer, Danielle
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison
    Bandyopadhyay, Dipankar
    Dent, Paul
    Malkin, Mark
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [28] Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide
    Donato, Vittorio
    Papaleo, Antonella
    Castrichino, Annamaria
    Banelli, Enzo
    Giangaspero, Felice
    Salvati, Maurizio
    Delfini, Roberto
    TUMORI, 2007, 93 (03) : 248 - 256
  • [29] Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
    Fang, Chen
    Wang, Kui
    Stephen, Zachary R.
    Mu, Qingxin
    Kievit, Forrest M.
    Chiu, Daniel T.
    Press, Oliver W.
    Zhang, Miqin
    ACS APPLIED MATERIALS & INTERFACES, 2015, 7 (12) : 6674 - 6682
  • [30] Hypofractionated intensity-modulated radiation therapy and temozolomide for patients with glioblastoma
    Souhami, Luis
    Roberge, David
    Kavan, Petr
    Muanza, Thierry
    Lambert, Christine
    Guiot, Marie Christine
    Del Maestro, Rolando
    Leblanc, Richard
    Shenouda, George
    NEURO-ONCOLOGY, 2007, 9 (04) : 583 - 583
12345